Icatibant acetate cas 138614-30-9
Icatibant Acetate antagonist na bradykinin B2 mai karɓa, wanda za'a iya amfani dashi don maganin angioedema na gado.
Icatibant (10-30μM) potentiatesangiotensinIII, butnotangiotensinII (contractionmediatedbyangiotensinAT1receChemicalbookptors), da Lys-des-Arg9-bradykinin, butnotdes-Arg9-bradykinin (sakamako ta hanyar masu karɓa nabradykininB1).
Icatibant (10-30μM) yana ƙarfafa angiotensin III, amma ba angiotensinII (masu karɓa ba) da Lys-des-Arg9-bradykinin, butnotdes-Arg9-bradykinin (yana tasiri ta hanyar masu karɓa nabradykininB1). Model Dabbobi: Berayen mata na nau'in CBA/J(H-Chemicalbook2k).
Sashi: 0.06,0.3, ko 1.5mg/kg.
Gudanarwa: Gudanar da subcutaneous sau biyu a rana.
Sakamakon: Tsawon mafi girman inewas93.6 ± 6.8mm tare da 1.5mg/kg sashi da 94.0± 4.1mm tare da kashi 0.3mg/kg, yana nuna babban tasiri na rigakafi akan ragewa.
Atebant acetate Properties Yanayin ajiya -20 ° C solubility DMSO: 65.0 (MaxConc.mg/mL); 47.63 (MaxConc. MM) Ethanol: 0.25 (MaxConc. MgChemicalbook/mL); 0.18 (MaxConc. MM) PBS (pH7.2): 10.0 (MaxConc. Mg/mL); 7.33 (MaxConc.mM) Acrystallinesolid
Lambar CAS 138614-30-9
Tsarin kwayoyin halitta C59H89N19O13S.C2H4O2
Nauyin kwayoyin halitta 1364.59EINECS lambar: -
Abubuwan Physicochemical na Altybant acetate
Yawaita 1.6g/cm3
Tsarin kwayoyin halitta C61H93N19O15S
Nauyin kwayoyin 1364.57000
Daidaitaccen taro 1363.68000
Icatibant acetate cas 138614-30-9
Icatibant Acetate antagonist na bradykinin B2 mai karɓa, wanda za'a iya amfani dashi don maganin angioedema na gado.
turanci mai suna
Lakabi na kasar Sin